Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
People on Ozempic may have fewer heart attacks, strokes, addictions—but more nausea, vomiting, stomach pain
Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.
TAG24 NEWS on MSN6m
Major study of weight-loss jabs shows slew of benefits but also risks
Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...